Inovio stock drops after Covid-19 vaccine developer reports large second-quarter loss
August 11, 2020 at 10:53 AM EDT
The company expects to begin late-stage testing of its Covid-19 vaccine candidate in September.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|